Device Trial Radar · NCT05016674
Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat
Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jul 21, 2021
Primary completion
Feb 1, 2023
Study completion May 1, 2023
Sponsor
- Lead sponsor
- Alma LasersNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 23, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure
Conditions
- Laser Assisted Liposuction
Interventions
LipoLife systemDevice
Abdominal Laser-Assisted Liposuction
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average adipose cell cluster sizeTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
William Jason Martin, MD
Denver, Colorado
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.